SCHEDULE 13G
Statement of Beneficial Ownership
CDT Equity Inc. Filed Acc 0001753926-26-000333
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| Ascent Partners Fund LLC | 255,657 | 9.9% |
| Ascent Partners LLC | 255,657 | 9.9% |
| Dominion Capital LLC | 255,657 | 9.9% |
| Dominion Capital GP LLC | 255,657 | 9.9% |
| Dominion Capital Holdings LLC | 255,657 | 9.9% |
| Masada Group Holdings LLC | 255,657 | 9.9% |
| Mikhail Gurevich | 255,657 | 9.9% |
| Gennadiy Gurevich | 255,657 | 9.9% |
| Alon Brenner | 255,657 | 9.9% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Stake history · largest stake in each 13D and 13G
- 2026-10-07 SCHEDULE 13G/A · Taylor Mark Andrew 3.4%
- 2026-10-07 SCHEDULE 13G/A · Wigglesworth Craig Stuart 3.4%
- 2026-09-09 SCHEDULE 13G · Wigglesworth Craig Stuart 9.6%
- 2026-09-02 SCHEDULE 13G · Taylor Mark Andrew 9.6%
- 2026-09-02 SCHEDULE 13D/A · Corvus Capital Ltd. 43.7%
- 2026-08-21 SCHEDULE 13G · Primary Development Fund (Cayman) SPC 2.97%
- 2026-08-21 SCHEDULE 13G · Primary Development Fund (Cayman) SPC 5.3%
- 2026-05-20 SCHEDULE 13G · Nirland Limited 1.6%
- 2026-05-14 SCHEDULE 13D/A · Andrew Regan 5.4%
- 2026-03-30 SCHEDULE 13D · Taylor Mark Andrew 43.79%
- 2026-02-18 SCHEDULE 13G · Ascent Partners Fund LLC 9.9%
- 2025-12-22 SCHEDULE 13D/A · Andrew Regan 19.1%
- 2025-09-22 SCHEDULE 13D/A · Andrew Regan 13.3%
- 2025-05-07 SCHEDULE 13G · Sarborg Ltd 16.4%
- 2025-04-10 SCHEDULE 13G/A · AstraZeneca PLC 1.1%
- 2022-02-14 SC 13D · Murphy Canyon Acquisition Sponsor, LLC 23.49%
- 2022-02-11 SC 13G · Saba Capital Management, L.P. 5.5%
- 2022-02-10 SC 13G · MMCAP International Inc. SPC 6.1%
Loading xslSCHEDULE_13G_X01/primary_doc.xml…